Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Merrimack Pharmaceuticals Inc (MACK)

Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Mar, 2024 Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income 201,370 -240 -280 -390 -270
Net Income Growth +84,004.51% +14.29% +28.20% -44.44% +44.90%

Balance Sheet

(Values in U.S. Thousands) Mar, 2024 Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023
Total Assets 244,320 19,190 19,300 19,450 19,640
Total Assets Growth +1,173.16% -0.57% -0.77% -0.97% -1.01%
Total Liabilities 22,670 440 490 410 460
Total Liabilities Growth +5,052.27% -10.20% +19.51% -10.87% -22.03%

Cash Flow

(Values in U.S. Thousands) Mar, 2024 Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023
Operating Cash Flow -1,310 -1,520 -1,230 -1,020 -360
Operating Cash Flow Growth +13.82% -23.58% -20.59% -183.33% +79.31%
Net Cash Flow 228,170 -13,450 -13,360 -9,310 -40
Change in Net Cash Flow +1,796.43% -0.67% -43.50% -23,175.58% -100.76%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot